Health Journal Online

Tag: prices

  • Trump Secures Major Win as AstraZeneca Joins Pfizer in Lowering US Drug Prices

    Trump Secures Major Win as AstraZeneca Joins Pfizer in Lowering US Drug Prices

    President Donald Trump secured a major victory Friday as AstraZeneca agreed to lower its prescription drug prices for Medicaid—a move that follows a similar deal made by Pfizer and marks a center point in the administration’s push for more affordable medicine.

    According to AP, the agreement, made public during a White House Oval Office event, commits AstraZeneca to “most–favored–nation” pricing for Medicaid.

    That means the company will match the lowest drug prices offered in other wealthy nations.

    Trump celebrated the deal, saying it could lead to US prices being “the lowest price anywhere in the world.”

    AstraZeneca CEO Pascal Soriot joined Trump for the announcement. With a wry tone, he later admitted that the negotiations had been intense: the president and his team “really kept me up at night.”

    Under the new deal, AstraZeneca will also guarantee the pricing standard for newly launched drugs.

    This move follows on the heels of Pfizer’s recent agreement with the administration. Both deals build off an executive order Trump signed in May: drugmakers were given the option to voluntarily reduce prices or face tighter limits on what the government will pay.


    Trump Touts AstraZeneca’s $4.5B Deal

    Trump took a swipe at AstraZeneca’s initial resistance, quipping, “The tariffs were a big reason he came here.”

    The president also highlighted AstraZeneca’s commitment to expand production in the US by announcing a new $4.5 billion manufacturing plant in Virginia, which is just part of a $50 billion investment plan through 2030.

    That facility alone is expected to create around 3,600 US jobs.

    AstraZeneca, based in Cambridge, UK, produces treatments such as Tagrisso for lung cancer, Lynparza for ovarian cancer, and Calquence for leukemia—together generating more than $7.5 billion in US sales last year.

    While the announcements were met with praise by drug-cost advocates, some experts warn that placing all hope on the drugmakers could be risky without stronger US policies to back them up.

    Questions remain over how much patients and states will truly benefit, given that Medicaid already secures a “best price” deal and most patients don’t pay full cost out of pocket, CBS News reported.

    Trump also introduced a new initiative: a website called TrumpRx.gov, coming in January 2026.

    Patients will be able to order medications directly from Roche and AstraZeneca through the site at reduced cash prices.

    Originally published on vcpost.com



    Source link

  • Marjorie Taylor Greene Calls Out ‘Absolutely Unaffordable’ Insurance Prices After Voting to Kick Millions Off Their Insurance

    Marjorie Taylor Greene Calls Out ‘Absolutely Unaffordable’ Insurance Prices After Voting to Kick Millions Off Their Insurance

    Rep. Marjorie Taylor Greene (R-GA) is going “Mom Mode” over the unaffordable cost of health insurance, weeks after signing the “Big, Beautiful Bill” that will strip millions of Americans of their health insurance.

    Friday morning, Greene railed against cost of living increases, including “all insurance being absolutely unaffordable,” noting her personal stake in the issue as a mother of three young adult children.

    “My children are 22, 25, and 27 and their generation is getting screwed,” she said. “I’m fighting for my kids and their entire generation. Their future is all that matters to me.”


    But critics were quick to note that legislation supported by Greene has only exacerbated the challenges highlighted by her post.

    According to a Congressional Budget Office report, 17 million Americans stand to lose their health insurance coverage when the “One Big, Beautiful Bill” takes effect in 2026. Greene voted in favor of the bill, which was signed into law by President Donald Trump on July 4.


    Greene did not reference the bill, pointing instead to “too much political drama.”

    “Regular Americans are exhausted with it all,” Greene continued. “They want their elected leaders to give a sh– about the people they represent.”


    “Now, I’m only operating in Mom Mode and it’s highly defensive and strategically offensive,” she claimed, though she did not indicate what strategy she intends to employ against the “skyrocketing” cost of living.

    Originally published on Latin Times



    Source link